doi:10.19982/j.issn.1000-6621.20240327

Abstract

CLC Number:

R378.91
R519

Figures/Tables 1

References 15

[1]	Bhatnagar M, Fisher A, Ramsaroop S, et al. Chylothorax: pathophysiology, diagnosis, and management-a comprehensive review. J Thorac Dis, 2024, 16(2): 1645-1661. doi:10.21037/jtd-23-1636. pmid: 38505027
[2]	Cholet C, Delalandre C, Monnier-Cholley L, et al. Nontraumatic chylothorax: nonenhanced MR lymphography. Radiographics, 2020, 40(6): 1554-1573. doi:10.1148/rg.2020200044. pmid: 33001788
[3]	Szkorupa M. Postoperative chylothorax review. Rozhl Chir, 2020, 99(10): 427-437. pmid: 33242960
[4]	Cherian S, Umerah OM, Tufail M, et al. Chylothorax in a patient with HIV-related kaposi’s sarcoma. BMJ Case Rep, 2019, 12 (1):e227641-e227645. doi:10.1136/bcr-2018-227641.
[5]	唐文娟. 3列大血管术后并发乳糜胸的护理体会. 实用临床护理学电子杂志, 2018, 3(26): 105-110. doi:10.3969/j.issn.2096-2479.2018.26.084.
[6]	Nadolski G. Nontraumatic chylothorax: diagnostic algorithm and treatment options. Tech Vasc Interv Radiol, 2016, 19(4): 286-290. doi:10.1053/j.tvir.2016.10.008. pmid: 27993324
[7]	张卉, 葛莉, 张煜涵, 等. 34例非结核分枝杆菌病的临床病理特征分析. 中国防痨杂志, 2024, 46(7): 756-762. doi:10.19982/j.issn.1000-6621.20240151.
[8]	中华医学会感染病学分会艾滋病学组. 艾滋病合并马尔尼菲篮状菌病诊疗专家共识(2024年更新版). 中国艾滋病性病, 2024, 30(6): 563-572. doi:10.13419/j.cnki.aids.2024.06.02.
[9]	Wang YG, Cheng JM, Ding HB, et al. Study on the clinical features and prognosis of penicilliosis marneffei without human immunodeficiency virus infection. Mycopathologia, 2018, 183(3):551-558. doi:10.1007/s11046-017-0236-3.
[10]	刘盛盛, 唐神结. 《非结核分枝杆菌病诊断与治疗指南(2020年版)》解读. 结核与肺部疾病杂志, 2021, 2(2): 108-115. doi:10.3760/cma.j.cn112147-20200508-00570.
[11]	Jiang J, Meng S, Huang S, et al. Effects of talaromyces marneffei infection on mortality of HIV/AIDS patients in southern china: a retrospective cohort study. Microbiol Infect, 2018, 25 (2): 233-241. doi:10.1016/j.cmi.2018.04.018.
[12]	段鸿飞. 非结核分枝杆菌病诊治六十年. 中国防痨杂志, 2024, 46(8): 863-868. doi:10.19982/j.issn.1000-6621.20240114.
[13]	中华医学会感染病学分会艾滋病学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2024版). 中华传染病杂志, 2024, 42(5): 257-284. doi:10.3760/cma.j.cn311365-20240328-00081.
[14]	初乃惠, 周文强, 沙巍. 非结核分枝杆菌病治疗药品超说明书用法专家共识. 中国防痨杂志, 2020, 42(8): 769-787. doi:10.3969/j.issn.1000-6621.2020.08.002.
[15]	Del Cueto-Aguilera á, Ibarra-Sifuentes HR, Delgado-García G, et al. Chylothorax and chylous ascites due to mycobacterium tuberculosis in an AIDS patient whose PCR tested negative. Pneumologia, 2016, 65 (3): 161-163. pmid: 29542896

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 15

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163.
[2]	Zhao Yue, Wang Haoran, Cheng Meijin, Wang Wei, Liang Ruixia, Huang Hairong. The evaluation of the smear-positive and Xpert-negative outcome as an early indicator of nontuberculous mycobacteria existence in clinical specimen [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 61-65.
[3]	Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang. Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76.
[4]	Ma Shiran, Chen Suting, Huang Hairong, Duan Hongfei. In vitro inhibitory and intracellular bactericidal activity of omadacycline against Mycobacterium abscessus [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1442-1447.
[5]	Li Cuiping, Chen Pinru, Xue Lijing, Zheng Shengkun. Nontuberculous mycobacterium parotid lymphadenitis in children: report of 3 cases and literature review [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1259-1265.
[6]	Liu Kejun, Zhang Haipeng, Wang Peng. Overview of genomic research on Mycobacteriophages [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1283-1292.
[7]	Chen Zhenhua, Guo Jingwei, Wang Jue, Hu Peilei, Yi Songlin, Liu Yi, Tan Yunhong. Study on detection methods of mixed infection with Mycobacterium tuberculosis complex and nontuberculous mycobacteria based on BACTEC MGIT 960 culture [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1243-1249.
[8]	Li Junli, Guo Xiaonan, Liang Yan, He Pu, Li Xiaochi, Zhao Aihua, Du Weixin, Wu Xueqiong, Zhu Bingdong, Xu Miao. Research advances and breakthroughs in tuberculosis vaccine [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1171-1184.
[9]	Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068.
[10]	Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei. Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
[11]	Duan Hongfei. Diagnosis and treatment of nontuberculous mycobacteria diseases in the past 60 years [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 863-868.
[12]	Zhang Lanyue, Wang Yingchao, Liu Weiyi, Shang Xuetian, Jia Hongyan, Zhu Chuanzhi, Zhang Zongde, Pan Liping. Study on the effect of thiol acetyltransferase mshD on the growth and stress response of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 935-941.
[13]	Cheng Mengli, Jiang Guanglu, Huo Fengmin, Xue Yi, Yu Xia. Evaluation of in vitro activity of fusidic acid against mycobacteria [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 461-466.
[14]	Pei Shaojun, Ou Xichao. Interpretation of the World Health Organization’s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 260-266.
[15]	Dong Yu, Pang Yu. Focusing on the diagnosis of pulmonary tuberculosis in sputum-free patients and exploring the potential of tongue swab substitution [J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1131-1133.